The original shielding letters and advice that have been sent out to people who are highly vulnerable to COVID-19 (coronavirus) infection stated that all recipients of the letter should completely isolate themselves from physical contact, not go outside of their homes for 12 weeks.
This advice was sent to all patients of the National Aspergillosis Centre (NAC) who have chronic pulmonary aspergillosis (CPA).
Patients who have allergic bronchopulmonary aspergillosis (ABPA), severe asthma and forms of aspergillosis other than CPA were informed of their vulnerability status by their local respiratory clinic or GP. Some will have been told to shield, others not but all shielding advice was to remain in place for 12 weeks from the day of receipt of the letter.
That advice for people shielding has now been amended to say that all shielding people should continue shielding until the end of June 2020.
Latest advice from Welsh government
Share this post
Latest News posts
Tracking Adverse Medication Events and Drug:Drug Interactions
January 29, 2019
Breaking Thought Cycles Using Mindfulness
January 29, 2019
Prescribe Happiness to Improve Our Health
January 29, 2019
What Happens When Patients Lead the Health Team?
January 29, 2019
Getting a grip on pain and the brain: Prof Lorimer Moseley
January 29, 2019
All day in hospital
January 29, 2019
How to produce a sputum sample when asked
January 29, 2019
Meet e-Patient Dave: Take control of your illness management
January 29, 2019
What healthcare will look like in 2020: Patient communication
January 29, 2019
How to use nebulised amphotericin
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video